Equillium Inc (EQ)
0.721
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 13:56
Equillium Enterprise Value: -0.3668M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -0.3668M |
| November 20, 2024 | -0.4341M |
| November 19, 2024 | -1.075M |
| November 18, 2024 | -1.749M |
| November 15, 2024 | -0.7353M |
| November 14, 2024 | -1.635M |
| November 13, 2024 | 1.773M |
| November 12, 2024 | 4.236M |
| November 11, 2024 | 0.7138M |
| November 08, 2024 | 1.139M |
| November 07, 2024 | 1.240M |
| November 06, 2024 | 0.7409M |
| November 05, 2024 | 0.5036M |
| November 04, 2024 | 0.6948M |
| November 01, 2024 | 3.525M |
| October 31, 2024 | 4.623M |
| October 30, 2024 | 23.01M |
| October 29, 2024 | 22.83M |
| October 28, 2024 | 22.30M |
| October 25, 2024 | 15.92M |
| October 24, 2024 | 17.34M |
| October 23, 2024 | 10.96M |
| October 22, 2024 | 13.09M |
| October 21, 2024 | 13.80M |
| October 18, 2024 | 14.15M |
| Date | Value |
|---|---|
| October 17, 2024 | 12.38M |
| October 16, 2024 | 13.09M |
| October 15, 2024 | 4.978M |
| October 14, 2024 | 4.964M |
| October 11, 2024 | 6.713M |
| October 10, 2024 | 6.040M |
| October 09, 2024 | 6.005M |
| October 08, 2024 | 7.780M |
| October 07, 2024 | 7.209M |
| October 04, 2024 | 4.758M |
| October 03, 2024 | 3.897M |
| October 02, 2024 | 3.986M |
| October 01, 2024 | 3.706M |
| September 30, 2024 | 3.596M |
| September 27, 2024 | -3.819M |
| September 26, 2024 | -5.314M |
| September 25, 2024 | -4.605M |
| September 24, 2024 | -4.248M |
| September 23, 2024 | -4.998M |
| September 20, 2024 | -3.188M |
| September 19, 2024 | -2.480M |
| September 18, 2024 | -3.188M |
| September 17, 2024 | -3.011M |
| September 16, 2024 | -2.834M |
| September 13, 2024 | -2.480M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.77M
Minimum
Mar 10 2023
436.89M
Maximum
Jul 13 2020
33.64M
Average
27.64M
Median
Nov 01 2022
Enterprise Value Benchmarks
| Matinas BioPharma Holdings Inc | -7.845M |
| Tenon Medical Inc | 2.839M |
| Alphatec Holdings Inc | 1.894B |
| Madrigal Pharmaceuticals Inc | 6.299B |
| Spero Therapeutics Inc | -11.41M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.007M |
| Revenue (Quarterly) | 12.16M |
| Total Expenses (Quarterly) | 12.84M |
| EPS Diluted (Quarterly) | -0.0002 |
| Profit Margin (Quarterly) | -0.06% |
| Earnings Yield | -19.44% |
| Normalized Earnings Yield | -19.44 |